Zhiping Chen

Dr. Zhiping Chen


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2016 in Protein & Cell
Verified
Journal Article
Open access
PDF file
YZYanjun Zhang
Yanjun Zhang
WCWenxian Chen
Wenxian Chen
GWGary Wong
Gary Wong
YBYuhai Bi
Yuhai Bi
JYJuying Yan
Juying Yan
ZCZhiping Chen
Zhiping Chen

1 July 2020 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
JCJunfang Chen
Junfang Chen
HHHanqing He
Hanqing He
WCWei Cheng
Wei Cheng
YLYan Liu
Yan Liu
ZSZhou Sun
Zhou Sun
ZCZhiping Chen
Zhiping Chen

27 September 2022 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
JTJianbin Tan
Jianbin Tan
YGYang Ge
Yang Ge
LMLeonardo Martinez
Leonardo Martinez
JSJimin Sun
Jimin Sun
CLChangwei Li
Changwei Li
HHHui Huang
Hui Huang
Coronavirus disease 2019 (COVID-19) asymptomatic cases are hard to identify, impeding transmissibility estimation. The value of COVID-19 transmissibility is worth further elucidation for key assumptions in further modelling studies. Through a population-based surveillance network, we collected data on 1342 confirmed cases with a 90-days follow-up for all asymptomatic cases. An age-stratified compartmental model containing contact information was built to estimate the transmissibility of symptomatic and asymptomatic COVID-19 cases. The difference in transmissibility of a symptomatic and asymptomatic case depended on age and was most distinct for the middle-age groups. The asymptomatic cases had a 66.7% lower transmissibility rate than symptomatic cases, and 74.1% (95% CI 65.9–80.7) of all asymptomatic cases were missed in detection. The average proportion of asymptomatic cases was 28.2% (95% CI 23.0–34.6). Simulation demonstrated that the burden of asymptomatic transmission increased as the epidemic continued and could potentially dominate total transmission. The transmissibility of asymptomatic COVID-19 cases is high and asymptomatic COVID-19 cases play a significant role in outbreaks.

10 June 2013 in Frontiers of Medicine
Verified
Journal Article
Closed access
PDF file
ECEnfu Chen
Enfu Chen
FWFenjuan Wang
Fenjuan Wang
HLHuakun Lv
Huakun Lv
YZYanjun Zhang
Yanjun Zhang
HDHua Ding
Hua Ding
SXShichang Xia
Shichang Xia


13 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FXFang Xu
Fang Xu
PYPing-Ping Yao
Ping-Ping Yao
YXYong Xia
Yong Xia
LQLei Qian
Lei Qian
ZYZhang-Nv Yang
Zhang-Nv Yang
HZHan-Ping Zhu
Han-Ping Zhu
Neurogenic pulmonary edema caused by severe brainstem encephalitis is the leading cause of death in young children infected by Enterovirus 71 (EV71). However, no pulmonary lesions have been found in EV71-infected transgenic or non-transgenic mouse models. Development of a suitable animal model is important for studying EV71 pathogenesis and assessing effect of therapeutic approaches. We had found neurological disorders in EV71-induced young gerbils previously. Here, we report severe pulmonary lesions characterized with pulmonary congestion and hemorrhage in a gerbil model for EV71 infection. In the EV71-infected gerbils, six 21-day-old or younger gerbils presented with a sudden onset of symptoms and rapid illness progression after inoculation with 1×105.5 TCID50 of EV71 via intraperitoneal (IP) or intramuscular (IM) route. Respiratory symptoms were observed along with interstitial pneumonia, pulmonary congestion and extensive lung hemorrhage could be detected in the lung tissues by histopathological examination. EV71 viral titer was found to be peak at late stages of infection. EV71-induced pulmonary lesions, together with severe neurological disorders were also observed in gerbils, accurately mimicking the disease process in EV71-infected patients. Passive transfer with immune sera from EV71 infected adult gerbils with a neutralizing antibody (GMT=89) prevented severe pulmonary lesion formation after lethal EV71 challenge. These results establish this gerbil model as a useful platform for studying the pathogenesis of EV71-induced pulmonary lesions, immunotherapy and antiviral drugs.